Survival is improved by antigen-specific cytotoxic T lymphocytes (CTL) responses after treatment with the vaccine Tedopi in HLA-A2 positive advanced non-small cell lung cancer (NSCLC) patients

Affiliation auteurs!!!! Error affiliation !!!!
TitreSurvival is improved by antigen-specific cytotoxic T lymphocytes (CTL) responses after treatment with the vaccine Tedopi in HLA-A2 positive advanced non-small cell lung cancer (NSCLC) patients
Type de publicationJournal Article
Year of Publication2019
AuteursBesse B, Felip E, Giaccone G, Dziadziuszko R, Quoix E, Hilgers W, Cappuzzo F, Borg C, Remon J, Poirier N, Costantini D, Vasseur B, Viteri S
JournalJOURNAL FOR IMMUNOTHERAPY OF CANCER
Volume7
Date PublishedNOV 6
Type of ArticleMeeting Abstract
ISSN2051-1426